These cross-disciplinary advances suggest that rationally designed metabolic interventions, guided by immune-metabolic profiling, may likewise be leveraged to rescue exhausted CD8+ T cells in sepsis and to synergize with cytokine therapy or checkpoint modulation. The gene discussed is CD8A; the disease is Sepsis.